Amanda Piquet
Analyst
Investigator, KAISA-8 Clinical Trial
Equibles does not estimate personal net worth.
About Amanda Piquet
Amanda Piquet is recorded as Analyst at Investigator, KAISA-8 Clinical Trial. Amanda Piquet has spoken on 1 investor event across 1 company, most recently for Kyverna Therapeutics, Inc. on April 22, 2026. The companies whose calls Amanda Piquet spoke on are classified in the Healthcare sector.
Amanda Piquet on recent calls
“I'm excited to present this unprecedented data. So the results showed MIPSEL delivered rapid, statistically significant, and clinically meaningful improvements across all primary and secondary endpoints at week 16, with the majority of patients regaining function.”
Affiliation history
-
Investigator, KAISA-8 Clinical Trial
Analyst
Transcript header (unverified)
Current